2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Rare Tumors
Rare tumors present a unique challenge in cancer research due to their infrequency and often limited understanding. To delve into this specialized field, start by conducting a thorough literature review to grasp the current state of knowledge and identify gaps in research. Utilize databases like PubMed and Google Scholar to access peer-reviewed articles, clinical trials, and case studies relevant to rare tumors. Collaborating with experts in oncology and pathology can provide valuable insights and guidance. Consider joining interdisciplinary research groups or networks focusing on rare cancers to leverage collective expertise and resources. Additionally, seek funding opportunities from organizations specializing in rare diseases to support your research endeavors. Embracing innovative technologies such as genomic sequencing and advanced imaging techniques can unveil novel insights into the biology and behavior of rare tumors. By combining comprehensive literature analysis, collaboration with experts, and innovative methodologies, you can advance understanding and treatment options for these challenging malignancies.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China